Thymocartin

This classification denotes a therapeutic hormone with the molecular formula C21H40N8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) M0H0SK3AD5, chemically known as l-valine, n-(n-(n(sup 2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)- but more generally known as thymocartin, which bears US NIH Compound Identifier 3033954. European Medicines Agency schedules Thymocartin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10991MIG. The term THYMOCARTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). THYMOCARTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule thymocartin under HS 29371900 and SITC 54154. As of Q4 2014, THYMOCARTIN remains US FDA's Preferred Term for this commodity. Thymocartin bears US NLM identifiers UMLS ID C0624592 and NCI Concept Code C90959. SMILES: O=C(NC(C(=O)NC(C(C)C)C(=O)O)CC(=O)O)C(NC(=O)C(N)CCC/N=C(/N)N)CCCCN.